APOE and acute lymphoblastic leukemia: The association between PPI use and incident all-cause dementia was observed particularly among the APOE ε4 heterozygous (+/−) population (HR, 1.46; 95% CI, 1.22–1.75; P < 0.001), and the interaction was statistically significant (P for interaction = 0.048; Fig. 3).